Liraglutide was as effective as a structured supervised lifestyle modification programme combining diet and exercise for reducing weight, liver damage, and liver fat at 26 weeks in obese Asians with nonalcoholic fatty liver disease (NAFLD), a study shows.
An additional benefit of canagliflozin when administered to patients with type 2 diabetes (T2D) and high cardiovascular (CV) risk may be a reduced risk of stroke, according to results from the CANVAS* Program.
Breakfast consumption does not seem to be a good approach for weight loss, regardless of established eating habit, suggest the results of a systematic review and meta-analysis. Caution must be observed when recommending breakfast for weight loss in adults due to its potential opposite effect.
Insulin plays an aetiological role in renal cell carcinoma (RCC), while obesity or having an elevated diastolic (DBP), but not systolic (SBP), blood pressure increases RCC risk, according to a recent study.
Asian patients with type 2 diabetes (T2D) and existing cardiovascular disease (CVD) who received empagliflozin in the EMPA-REG OUTCOME* trial had a reduced risk of adverse renal events, a finding consistent with that of the overall trial population.
Skin autofluorescence measurement can be used to estimate the risk of developing type 2 diabetes, cardiovascular disease (CVD) and mortality, independent of glycaemic measures and traditional risk factors, such as metabolic syndrome, according to a recent study.
The three-drug combination of telmisartan, amlodipine and rosuvastatin yields significant reductions in blood pressure and low-density lipoprotein cholesterol levels in patients with hypertension and dyslipidaemia while having a good safety profile and tolerability, according to data from the J-TAROS* trial.
Gastric bypass proves beneficial to hypertensive individuals with low-to-moderate risk obesity, with data from the substudy of GATEWAY trial showing that the procedure reduces the need for antihypertensive medications, improves blood pressure (BP) variability and cuts the burden of resistant hypertension.
Diabetic retinopathy is a leading cause of blindness, making early detection of this condition crucial. Dr Yong Shao Onn from the Eagle Eye Centre at Mt Alvernia Hospital, Singapore, speaks to Roshini Claire Anthony on the diagnosis and treatment options.